Account Executive, Flow Neuroscience
1 day a week in office (Battersea Power Station, London)
Wearable home treatment for depression
Open for applications
Wearable home treatment for depression
21-100 employees
Open for applications
1 day a week in office (Battersea Power Station, London)
21-100 employees
Company mission
To find new ways of treating mental health issues, using science and technology.
Role
Who you are
- You have first-hand experience convincing a target audience to try something completely new. This is the single most important requirement
- You have high energy and motivation. This role will require you to be on the road, meeting clinicians across the country
- You are methodical and analytical. You record the results of your work and can quickly determine what is and isn’t working
- You have a lifelong learning attitude with a continuous eye on development and improvement
- You can deliver exceptional customer service. We are building the Flow brand and every customer touchpoint is either a positive or a negative step towards the brand we want. This is something we take really seriously at Flow
- You have strong emotional intelligence and can form lasting customer relationships
What the job involves
- The goal of Flow’s B2B business is to integrate Flow into clinical treatment pathways. This means clinicians (psychiatrists, psychologists etc.) recommending Flow to their patients
- Your role is to get clinicians across the UK to try Flow. You will be out in the field, meeting face to face (or virtually) with clinicians (private and NHS) taking them through Flow’s data, how the product works and how it can help their patients and their business/NHS trust
- You will handle both inbound leads and handle outbound leads, proactively seeking new business opportunities
Salary benchmarks
Our take
Despite the prevalence of mental health conditions such as anxiety and depression, medicine has been relatively slow to respond with new treatment options. Particularly, at-home treatment has been limited to medication, or more recently virtual talk therapy. Flow Neuroscience has developed a wearable tDCS (transcranial Direct Current Stimulation) device for patients to use at home, with a complementary app to help manage the symptoms of major depressive disorder.
Flow’s treatment, the first of its kind approved for home use in Europe, allows users to administer tCDS without a doctor and away from a clinical setting. The company has been committed to following the rigorous medical research and testing framework, with the device undergoing early trials in the UK and EU, which have so far received positive results from users.
In 2022, Flow Neuroscience collaborated with Curebase to launch a large-scale FDA-approved clinical trial of its product. Off the back of this trial, the company entered the MedTech Innovator support programme in 2023. It will also seek FDA approval for its headset, which if successful will open the door for client reach expansion across the UK, EU, and US.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
Few candidates hear
back within 2 weeks
Company
Funding (last 2 of 3 rounds)
Aug 2021
$8.9m
SERIES A
Jul 2019
$1.4m
EARLY VC
Total funding: $11.4m
Company benefits
- Remote & hybrid options
- Flexible working hours
- Be part of a small team scaling a cutting-edge product that could change the way the world thinks about mental health treatment
Company HQ
Gamla staden, Malmö, Skåne County
Articles
Leadership
Daniel Månsson
(Chief Clinical Officer)Former CEO of the company. Previously a Clinical Psychologist at Østfold Hospital Trust.
Erik M. Rehn
(CTO)Co-Founder and Board Member at Slagkryssaren. Co-Founder and former VP at Stockholm.AI.
Share this job
View 1 more job at Flow Neuroscience